Typicality: | 0.352 |
Saliency: | 0.240 |
randomly | 13 | manner |
to groups | 3 | other |
subject → be assigned to → the placebo group | 6 |
subject → be assigned to → a placebo group | 5 |
subject → be assigned to → placebo group | 5 |
subject → be in → the placebo group | 3 |
negative | neutral | positive |
0.165 | 0.804 | 0.031 |
Raw frequency | 19 |
Normalized frequency | 0.240 |
Modifier score | 0.500 |
Perplexity | 26.548 |